Acumen Pharmaceuticals Inc (NASDAQ: ABOS) kicked off on Tuesday, up 4.09% from the previous trading day, before settling in for the closing price of $2.2. Over the past 52 weeks, ABOS has traded in a range of $0.86-$3.36.
During the last 5-year period, the sales drop of Healthcare Sector giant was -54.87%. While this was happening, its average annual earnings per share was recorded -31.61%. With a float of $46.91 million, this company’s outstanding shares have now reached $60.57 million.
Acumen Pharmaceuticals Inc (ABOS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Acumen Pharmaceuticals Inc is 22.56%, while institutional ownership is 54.75%. The most recent insider transaction that took place on Jan 23 ’25, was worth 49,633. In this transaction CFO & Chief Business Officer of this company sold 28,902 shares at a rate of $1.72, taking the stock ownership to the 231,744 shares. Before that another transaction happened on Jan 21 ’25, when Company’s CFO & Chief Business Officer sold 4,364 for $1.60, making the entire transaction worth $6,986. This insider now owns 260,646 shares in total.
Acumen Pharmaceuticals Inc (ABOS) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.5 earnings per share (EPS), lower than consensus estimate (set at -0.3) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -31.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.19% during the next five years compared to -54.87% drop over the previous five years of trading.
Acumen Pharmaceuticals Inc (NASDAQ: ABOS) Trading Performance Indicators
Take a look at Acumen Pharmaceuticals Inc’s (ABOS) current performance indicators. Last quarter, stock had a quick ratio of 5.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.27, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -1.67 in one year’s time.
Technical Analysis of Acumen Pharmaceuticals Inc (ABOS)
Looking closely at Acumen Pharmaceuticals Inc (NASDAQ: ABOS), its last 5-days average volume was 0.47 million, which is a jump from its year-to-date volume of 0.34 million. As of the previous 9 days, the stock’s Stochastic %D was 67.07%.
During the past 100 days, Acumen Pharmaceuticals Inc’s (ABOS) raw stochastic average was set at 87.94%, which indicates a significant increase from 72.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.24 in the past 14 days, which was higher than the 0.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.65, while its 200-day Moving Average is $1.36. However, in the short run, Acumen Pharmaceuticals Inc’s stock first resistance to watch stands at $2.46. Second resistance stands at $2.63. The third major resistance level sits at $2.80. If the price goes on to break the first support level at $2.12, it is likely to go to the next support level at $1.95. Should the price break the second support level, the third support level stands at $1.78.
Acumen Pharmaceuticals Inc (NASDAQ: ABOS) Key Stats
The company with the Market Capitalisation of 138.71 million has total of 60,573K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -102,330 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -40,950 K.
